In response to “who are the 10%? – Non eligibility of cystic fibrosis (CF) patients for highly effective modulator therapies”

Meghan E. McGarry*, Susanna A. McColley, Jennifer Taylor-Cousar

*Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

1 Scopus citations
Original languageEnglish (US)
Article number106953
JournalRespiratory Medicine
StatePublished - Oct 2022

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this